☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Gout
Eisai Signs a License Agreement with FUJI YAKUHIN for Dotinurad to Treat Hyperuricemia and Gout in China
February 26, 2020
Ironwood Terminated Rights of Zurampic lesinurad and Duzallo lesinurad/allopurinol Deal with AZ
August 7, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
